Key Players in the Pharmacovigilance Market, Segmentation, Size, Shares, and Revenue Analysis
Pharmacovigilance is referred to the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance is fundamentally based on the qualitative and quantitative study of spontaneous adverse drug reactions reports, followed by a clinical assessment with respects to its impact on the overall safety profile of the drug. It is particularly useful for identifying potential safety signals of a rare adverse event or in orphan disease settings where exposure data are limited prior to marketing. The purpose of pharmacovigilance is to enhance patient care and patient safety in relation to the use of medicines according to the life cycle of a health product. Pharmacovigilance has grown significantly in recent years and its importance in the healthcare system has been recognized worldwide.
To know the scope of our report get a sample on Pharmacovigilance Market:
https://www.axiommrc.com/request-for-sample/10141-pharmacovigilance-market-report
Pharmacovigilance Market Dynamics
The pharmacovigilance market is driven by increasing number
of ADRs coupled with potential threats to the consumers and increasing
geriatric population. Older population are more prone to the ADR’s. The
large-scale multicentre UK study found that in older patients, the most
prevalent forms of MRH were adverse drug reactions (ADRs). ADR imposes a
significant burden on healthcare systems and is one of the prominent causes of
morbidity in developed countries.
Besides, growing demand for continuous pharmacovigilance for
efficient surveillance of ADRs will render several growth opportunities for the
market expansion. Increasing acceptance and adoption of outsourcing services by
healthcare companies will stimulate pharmacovigilance (PV) market growth during
the forthcoming years.
Pharmacovigilance
Market Segmental Highlights
The report analyses the global
pharmacovigilance market based on clinical trial phase, service provider, type
and geography.
Pharmacovigilance
Market By Service Provider
In house and contract manufacturing are the ways of
obtaining pharmacovigilance services. Increasing acceptance and adoption of
outsourcing services by healthcare companies to relive pressure on budget will
stimulate contract manufacturing segmental growth during the forthcoming years.
Outsourcing eliminates the risk of business overhead costs as well as
deployment of pharmacovigilance resources. Therefore, there is increasing trend
of shifting pharmacovigilance outsourcing.
Pharmacovigilance
Market By Type
Pharmacovigilance Market by Type is categorised into
spontaneous reporting, intensified ADR reporting, targeted spontaneous
reporting, cohort event monitoring and EHR mining. Spontaneous reporting is by
nature a passive approach to pharmacovigilance (PV), relying entirely on the
motivation of individuals to report suspected adverse drug reactions (ADRs) to
a local or national pharmacovigilance centre.
It is widely used in in the detection of new, serious, and rare ADRs and
serves as an efficient and inexpensive method.
Pharmacovigilance
Market By Clinical Trial
Pharmacovigilance market by clinical trial is segmented into
Pre-Clinical, Phase I, II, III, IV.
Phase IV clinical trial deals securing an additional safety measure for
the drugs undergoing clinical trials. Phase IV is a vital stage of clinical
trials as unpredicted adverse drug reactions can be discovered in this stage.
Thus, the data collected and assessed during this stage is anticipated to be of
the highest relevance, endorsed to intensive drug testing on enormous
demographics patient base of highest relevance after commercialization of the
drug.
Pharmacovigilance
Market By Geography
Based on geography, the global pharmacovigilance market is
segmented into North America, Europe, Asia Pacific and Rest of the World. North
America accounted for the largest market share owing to the presence of key
pharmaceutical and medical devices player coupled with the increasing
investment in novel drug development by major players in this region.
Pharmacovigilance
Market Key Players
Key players in the global Pharmacovigilance market include
Accenture, Linical Accelovance, Capgemini, ITClinical, FMD K&L, IQVIA,
Cognizant, Laboratory Corporation of America Holding, IBM Corporation;
ArisGlobal, ICON plc, TAKE Solutions Ltd., Wipro Ltd. , United BioSource
Corporation, PAREXEL International Corporation, BioClinica Inc. and others
Key Development:
September 2016: Boehringer Ingelheim announced a long-term
collaboration with ViraTherapeutics, a biopharma company developing
immunotherapeutic for cancer treatment. This collaboration is intended to
develop a novel technology for oncology and to investigate clinical testing of
Vesicular Stomatitis Virus Glycoprotein (VSV-GP) in phase I trial.
June 2015: QuintilesIMS launched Infosario One Mobile App, a
mobile based application that enables access to important clinical trial
information. The application provides instant access to start-up, recruitment
and compliance information as well as updates on data queries. This product
launch enabled company to garner high market share and sustain market
competition.
Buy now Pharmacovigilance
Market Report https://www.axiommrc.com/buy_now/10141-pharmacovigilance-market-report
About Us:
Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.
Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.
Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.
Contact Us:
Axiom Market
Research & Consulting™
3 Germay Dr. Ste
4 - 4666
Wilmington DE
19804
U.S.:- + 1 (845)
875-9786
U.K.:- + 44 (0)
20 3286 9707
Email: sales@axiommrc.com
Website: https://www.axiommrc.com/
Blog: https://industrywatch24.com/
Follow On
LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/
Twitter: https://twitter.com/AxiommrcCom
Comments
Post a Comment